In both obese and non-obese mouse models, IGFBP-1 overexpression was associated with reduced blood pressure, improved insulin sensitivity, enhanced vasodilation, increased endothelial nitric oxide production, and protection against atherosclerosis [53]. Here, IGFBP1 is linked to atherosclerosis.